Search

Your search keyword '"Guo, Yongli"' showing total 698 results
Start Over Author "Guo, Yongli"
698 results on '"Guo, Yongli"'

56. TAF1D promotes proliferation by transcriptionally activating G2 /M phase‐related genes inMYCN‐amplified neuroblastoma

Author

Zhang, Xuan, primary, Zhan, Shijia, additional, Guan, Xiaoxing, additional, Zhang, Yanli, additional, Lu, Jie, additional, Yu, Yongbo, additional, Jin, Yaqiong, additional, Yang, Yeran, additional, Chu, Ping, additional, Hong, Enyu, additional, Yang, Hui, additional, Ren, Huimin, additional, Geng, Di, additional, Wang, Yadi, additional, Zhou, Pingping, additional, Guo, Yongli, additional, and Chang, Yan, additional

Published
2023
Full Text
View/download PDF

57. Data from Comparing Histone Deacetylase Inhibitor Responses in Genetically Engineered Mouse Lung Cancer Models and a Window of Opportunity Trial in Patients with Lung Cancer

Author

Ma, Tian, primary, Galimberti, Fabrizio, primary, Erkmen, Cherie P., primary, Memoli, Vincent, primary, Chinyengetere, Fadzai, primary, Sempere, Lorenzo, primary, Beumer, Jan H., primary, Anyang, Bean N., primary, Nugent, William, primary, Johnstone, David, primary, Tsongalis, Gregory J., primary, Kurie, Jonathan M., primary, Li, Hua, primary, DiRenzo, James, primary, Guo, Yongli, primary, Freemantle, Sarah J., primary, Dragnev, Konstantin H., primary, and Dmitrovsky, Ethan, primary

Published
2023
Full Text
View/download PDF

58. Supplementary Figure 1 from Evidence for the Ubiquitin Protease UBP43 as an Antineoplastic Target

Author

Guo, Yongli, primary, Chinyengetere, Fadzai, primary, Dolinko, Andrey V., primary, Lopez-Aguiar, Alexandra, primary, Lu, Yun, primary, Galimberti, Fabrizio, primary, Ma, Tian, primary, Feng, Qing, primary, Sekula, David, primary, Freemantle, Sarah J., primary, Andrew, Angeline S., primary, Memoli, Vincent, primary, and Dmitrovsky, Ethan, primary

Published
2023
Full Text
View/download PDF

59. Supplementary Figure 5 from Evidence for the Ubiquitin Protease UBP43 as an Antineoplastic Target

Author

Guo, Yongli, primary, Chinyengetere, Fadzai, primary, Dolinko, Andrey V., primary, Lopez-Aguiar, Alexandra, primary, Lu, Yun, primary, Galimberti, Fabrizio, primary, Ma, Tian, primary, Feng, Qing, primary, Sekula, David, primary, Freemantle, Sarah J., primary, Andrew, Angeline S., primary, Memoli, Vincent, primary, and Dmitrovsky, Ethan, primary

Published
2023
Full Text
View/download PDF

60. Supplementary Figure 2 from Comparing Histone Deacetylase Inhibitor Responses in Genetically Engineered Mouse Lung Cancer Models and a Window of Opportunity Trial in Patients with Lung Cancer

Author

Ma, Tian, primary, Galimberti, Fabrizio, primary, Erkmen, Cherie P., primary, Memoli, Vincent, primary, Chinyengetere, Fadzai, primary, Sempere, Lorenzo, primary, Beumer, Jan H., primary, Anyang, Bean N., primary, Nugent, William, primary, Johnstone, David, primary, Tsongalis, Gregory J., primary, Kurie, Jonathan M., primary, Li, Hua, primary, DiRenzo, James, primary, Guo, Yongli, primary, Freemantle, Sarah J., primary, Dragnev, Konstantin H., primary, and Dmitrovsky, Ethan, primary

Published
2023
Full Text
View/download PDF

61. Supplementary Figure 1 from Comparing Histone Deacetylase Inhibitor Responses in Genetically Engineered Mouse Lung Cancer Models and a Window of Opportunity Trial in Patients with Lung Cancer

Author

Ma, Tian, primary, Galimberti, Fabrizio, primary, Erkmen, Cherie P., primary, Memoli, Vincent, primary, Chinyengetere, Fadzai, primary, Sempere, Lorenzo, primary, Beumer, Jan H., primary, Anyang, Bean N., primary, Nugent, William, primary, Johnstone, David, primary, Tsongalis, Gregory J., primary, Kurie, Jonathan M., primary, Li, Hua, primary, DiRenzo, James, primary, Guo, Yongli, primary, Freemantle, Sarah J., primary, Dragnev, Konstantin H., primary, and Dmitrovsky, Ethan, primary

Published
2023
Full Text
View/download PDF

62. Data from Evidence for the Ubiquitin Protease UBP43 as an Antineoplastic Target

Author

Guo, Yongli, primary, Chinyengetere, Fadzai, primary, Dolinko, Andrey V., primary, Lopez-Aguiar, Alexandra, primary, Lu, Yun, primary, Galimberti, Fabrizio, primary, Ma, Tian, primary, Feng, Qing, primary, Sekula, David, primary, Freemantle, Sarah J., primary, Andrew, Angeline S., primary, Memoli, Vincent, primary, and Dmitrovsky, Ethan, primary

Published
2023
Full Text
View/download PDF

63. Supplementary Figure 4 from Evidence for the Ubiquitin Protease UBP43 as an Antineoplastic Target

Author

Guo, Yongli, primary, Chinyengetere, Fadzai, primary, Dolinko, Andrey V., primary, Lopez-Aguiar, Alexandra, primary, Lu, Yun, primary, Galimberti, Fabrizio, primary, Ma, Tian, primary, Feng, Qing, primary, Sekula, David, primary, Freemantle, Sarah J., primary, Andrew, Angeline S., primary, Memoli, Vincent, primary, and Dmitrovsky, Ethan, primary

Published
2023
Full Text
View/download PDF

64. Supplementary Figure Legend from Evidence for the Ubiquitin Protease UBP43 as an Antineoplastic Target

Author

Guo, Yongli, primary, Chinyengetere, Fadzai, primary, Dolinko, Andrey V., primary, Lopez-Aguiar, Alexandra, primary, Lu, Yun, primary, Galimberti, Fabrizio, primary, Ma, Tian, primary, Feng, Qing, primary, Sekula, David, primary, Freemantle, Sarah J., primary, Andrew, Angeline S., primary, Memoli, Vincent, primary, and Dmitrovsky, Ethan, primary

Published
2023
Full Text
View/download PDF

65. Supplementary Figure 6 from Evidence for the Ubiquitin Protease UBP43 as an Antineoplastic Target

Author

Guo, Yongli, primary, Chinyengetere, Fadzai, primary, Dolinko, Andrey V., primary, Lopez-Aguiar, Alexandra, primary, Lu, Yun, primary, Galimberti, Fabrizio, primary, Ma, Tian, primary, Feng, Qing, primary, Sekula, David, primary, Freemantle, Sarah J., primary, Andrew, Angeline S., primary, Memoli, Vincent, primary, and Dmitrovsky, Ethan, primary

Published
2023
Full Text
View/download PDF

66. Supplementary Figure 7 from Evidence for the Ubiquitin Protease UBP43 as an Antineoplastic Target

Author

Guo, Yongli, primary, Chinyengetere, Fadzai, primary, Dolinko, Andrey V., primary, Lopez-Aguiar, Alexandra, primary, Lu, Yun, primary, Galimberti, Fabrizio, primary, Ma, Tian, primary, Feng, Qing, primary, Sekula, David, primary, Freemantle, Sarah J., primary, Andrew, Angeline S., primary, Memoli, Vincent, primary, and Dmitrovsky, Ethan, primary

Published
2023
Full Text
View/download PDF

67. Supplementary Figure 3 from Evidence for the Ubiquitin Protease UBP43 as an Antineoplastic Target

Author

Guo, Yongli, primary, Chinyengetere, Fadzai, primary, Dolinko, Andrey V., primary, Lopez-Aguiar, Alexandra, primary, Lu, Yun, primary, Galimberti, Fabrizio, primary, Ma, Tian, primary, Feng, Qing, primary, Sekula, David, primary, Freemantle, Sarah J., primary, Andrew, Angeline S., primary, Memoli, Vincent, primary, and Dmitrovsky, Ethan, primary

Published
2023
Full Text
View/download PDF

68. Supplementary Figure Legend from Comparing Histone Deacetylase Inhibitor Responses in Genetically Engineered Mouse Lung Cancer Models and a Window of Opportunity Trial in Patients with Lung Cancer

Author

Ma, Tian, primary, Galimberti, Fabrizio, primary, Erkmen, Cherie P., primary, Memoli, Vincent, primary, Chinyengetere, Fadzai, primary, Sempere, Lorenzo, primary, Beumer, Jan H., primary, Anyang, Bean N., primary, Nugent, William, primary, Johnstone, David, primary, Tsongalis, Gregory J., primary, Kurie, Jonathan M., primary, Li, Hua, primary, DiRenzo, James, primary, Guo, Yongli, primary, Freemantle, Sarah J., primary, Dragnev, Konstantin H., primary, and Dmitrovsky, Ethan, primary

Published
2023
Full Text
View/download PDF

69. Supplementary Figure 3 from Comparing Histone Deacetylase Inhibitor Responses in Genetically Engineered Mouse Lung Cancer Models and a Window of Opportunity Trial in Patients with Lung Cancer

Author

Ma, Tian, primary, Galimberti, Fabrizio, primary, Erkmen, Cherie P., primary, Memoli, Vincent, primary, Chinyengetere, Fadzai, primary, Sempere, Lorenzo, primary, Beumer, Jan H., primary, Anyang, Bean N., primary, Nugent, William, primary, Johnstone, David, primary, Tsongalis, Gregory J., primary, Kurie, Jonathan M., primary, Li, Hua, primary, DiRenzo, James, primary, Guo, Yongli, primary, Freemantle, Sarah J., primary, Dragnev, Konstantin H., primary, and Dmitrovsky, Ethan, primary

Published
2023
Full Text
View/download PDF

70. Supplementary Figure 2 from Evidence for the Ubiquitin Protease UBP43 as an Antineoplastic Target

Author

Guo, Yongli, primary, Chinyengetere, Fadzai, primary, Dolinko, Andrey V., primary, Lopez-Aguiar, Alexandra, primary, Lu, Yun, primary, Galimberti, Fabrizio, primary, Ma, Tian, primary, Feng, Qing, primary, Sekula, David, primary, Freemantle, Sarah J., primary, Andrew, Angeline S., primary, Memoli, Vincent, primary, and Dmitrovsky, Ethan, primary

Published
2023
Full Text
View/download PDF

75. Multiple microRNAs function as self-protective modules in acetaminophen-induced hepatotoxicity in humans

Author

Yu, Dianke, Wu, Leihong, Gill, Pritmohinder, Tolleson, William H., Chen, Si, Sun, Jinchun, Knox, Bridgett, Jin, Yaqiong, Xiao, Wenming, Hong, Huixiao, Wang, Yong, Ren, Zhen, Guo, Lei, Mei, Nan, Guo, Yongli, Yang, Xi, Shi, Leming, Chen, Yinting, Zeng, Linjuan, Dreval, Kostiantyn, Tryndyak, Volodymyr, Pogribny, Igor, Fang, Hong, Shi, Tieliu, McCullough, Sandra, Bhattacharyya, Sudeepa, Schnackenberg, Laura, Mattes, William, Beger, Richard D., James, Laura, Tong, Weida, and Ning, Baitang

Published
2018
Full Text
View/download PDF

78. Supplementary Figure 1 from Functional Genetic Variations in Cytotoxic T-Lymphocyte Antigen 4 and Susceptibility to Multiple Types of Cancer

Author

Sun, Tong, primary, Zhou, Yifeng, primary, Yang, Ming, primary, Hu, Zhibin, primary, Tan, Wen, primary, Han, Xiaohong, primary, Shi, Yuankai, primary, Yao, Jiarui, primary, Guo, Yongli, primary, Yu, Dianke, primary, Tian, Tian, primary, Zhou, Xiaoyi, primary, Shen, Hongbing, primary, and Lin, Dongxin, primary

Published
2023
Full Text
View/download PDF

79. Supplementary Figure 1 from Blockade of the Ubiquitin Protease UBP43 Destabilizes Transcription Factor PML/RARα and Inhibits the Growth of Acute Promyelocytic Leukemia

Author

Guo, Yongli, primary, Dolinko, Andrey V., primary, Chinyengetere, Fadzai, primary, Stanton, Bruce, primary, Bomberger, Jennifer M., primary, Demidenko, Eugene, primary, Zhou, Da-Cheng, primary, Gallagher, Robert, primary, Ma, Tian, primary, Galimberti, Fabrizio, primary, Liu, Xi, primary, Sekula, David, primary, Freemantle, Sarah, primary, and Dmitrovsky, Ethan, primary

Published
2023
Full Text
View/download PDF

81. Supplementary Methods from Functional Genetic Variations in Cytotoxic T-Lymphocyte Antigen 4 and Susceptibility to Multiple Types of Cancer

Author

Sun, Tong, primary, Zhou, Yifeng, primary, Yang, Ming, primary, Hu, Zhibin, primary, Tan, Wen, primary, Han, Xiaohong, primary, Shi, Yuankai, primary, Yao, Jiarui, primary, Guo, Yongli, primary, Yu, Dianke, primary, Tian, Tian, primary, Zhou, Xiaoyi, primary, Shen, Hongbing, primary, and Lin, Dongxin, primary

Published
2023
Full Text
View/download PDF

82. Data from Blockade of the Ubiquitin Protease UBP43 Destabilizes Transcription Factor PML/RARα and Inhibits the Growth of Acute Promyelocytic Leukemia

Author

Guo, Yongli, primary, Dolinko, Andrey V., primary, Chinyengetere, Fadzai, primary, Stanton, Bruce, primary, Bomberger, Jennifer M., primary, Demidenko, Eugene, primary, Zhou, Da-Cheng, primary, Gallagher, Robert, primary, Ma, Tian, primary, Galimberti, Fabrizio, primary, Liu, Xi, primary, Sekula, David, primary, Freemantle, Sarah, primary, and Dmitrovsky, Ethan, primary

Published
2023
Full Text
View/download PDF

88. Additional file 1 of BPTF in bone marrow provides a potential progression biomarker regulated by TFAP4 through the PI3K/AKT pathway in neuroblastoma

Author

Jiang, Chiyi, Yang, Yeran, He, Sidou, Yue, Zhixia, Xing, Tianyu, Chu, Ping, Yang, Wenfa, Chen, Hui, Zhao, Xiaoxi, Yu, Yongbo, Zhang, Xuan, Su, Yan, Guo, Yongli, and Ma, Xiaoli

Abstract

Additional file 1: Figure S1. A GFP fluorescence imaging of 2 unique shRNA constructs targeting BPTF in SK-N-BE (2) cells 96 hours after lentiviral infection, when observed best transfection efficiency. Scale bar is 50 μm. B Quantitative of BPTF after 96h infection with BPTF knockdown lentiviral, as detected by RT-PCR [mean, 1.222 vs. 0.845 vs. 0.972]. C Sequencing results of the BPTF KO cell in SK-N-BE (2) compared with Ctrl. D Western blot of BPTF in SK-N-BE (2) cell with BPTF KO [mean, 0.386 vs. 0.000]. E, G Sequencing results of the BPTF KO cell in SH-SY5Y compared with Ctrl. F, H Representative western blot of BPTF in SH-SY5Y cell [mean, 0.442 vs. 0.000, D; 0.225 vs. 0.000, F] with BPTF KO. Error bars represent SEM. The data are representative of at least three independent experiments. * P

Published
2023
Full Text
View/download PDF

89. Additional file 3 of BPTF in bone marrow provides a potential progression biomarker regulated by TFAP4 through the PI3K/AKT pathway in neuroblastoma

Author

Jiang, Chiyi, Yang, Yeran, He, Sidou, Yue, Zhixia, Xing, Tianyu, Chu, Ping, Yang, Wenfa, Chen, Hui, Zhao, Xiaoxi, Yu, Yongbo, Zhang, Xuan, Su, Yan, Guo, Yongli, and Ma, Xiaoli

Abstract

Additional file 3: Figure S3. A The STRING database hinted that TFAP4 was one of the higher-ranked related molecules associated with BPTF. B The GEO NB cohorts showed that the expression of BPTF and TFAP4 were significantly positively correlated (n=498). r=0.211, P

Published
2023
Full Text
View/download PDF

90. Additional file 2 of BPTF in bone marrow provides a potential progression biomarker regulated by TFAP4 through the PI3K/AKT pathway in neuroblastoma

Author

Jiang, Chiyi, Yang, Yeran, He, Sidou, Yue, Zhixia, Xing, Tianyu, Chu, Ping, Yang, Wenfa, Chen, Hui, Zhao, Xiaoxi, Yu, Yongbo, Zhang, Xuan, Su, Yan, Guo, Yongli, and Ma, Xiaoli

Abstract

Additional file 2: Figure S2. A SH-SY5Y cell growth following BPTF KO shown by colony formation assay [mean, 114.330 vs. 81.330 vs. 45.000]. Error bars represent SEM. B SH-SY5Y cell migration following BPTF KO shown by RTCA. Error bars represent SD. The data are representative of at least three independent experiments. * P

Published
2023
Full Text
View/download PDF

93. TAF1D promotes proliferation by transcriptionally activating G2/M phase‐related genes in MYCN‐amplified neuroblastoma.

Author

Zhang, Xuan, Zhan, Shijia, Guan, Xiaoxing, Zhang, Yanli, Lu, Jie, Yu, Yongbo, Jin, Yaqiong, Yang, Yeran, Chu, Ping, Hong, Enyu, Yang, Hui, Ren, Huimin, Geng, Di, Wang, Yadi, Zhou, Pingping, Guo, Yongli, and Chang, Yan

Abstract

High‐risk neuroblastoma (HR‐NB) is an aggressive childhood cancer that responds poorly to currently available therapies and is associated with only about a 50% 5‐year survival rate. MYCN amplification is a critical driver of these aggressive tumors, but so far there have not been any approved treatments to effectively treat HR‐NB by targeting MYCN or its downstream effectors. Thus, the identification of novel molecular targets and therapeutic strategies to treat children diagnosed with HR‐NB represents an urgent unmet medical need. Here, we conducted a targeted siRNA screening and identified TATA box‐binding protein‐associated factor RNA polymerase I subunit D, TAF1D, as a critical regulator of the cell cycle and proliferation in HR‐NB cells. Analysis of three independent primary NB cohorts determined that high TAF1D expression correlated with MYCN‐amplified, high‐risk disease and poor clinical outcomes. TAF1D knockdown more robustly inhibited cell proliferation in MYCN‐amplified NB cells compared with MYCN‐non‐amplified NB cells, as well as suppressed colony formation and inhibited tumor growth in a xenograft mouse model of MYCN‐amplified NB. RNA‐seq analysis revealed that TAF1D knockdown downregulates the expression of genes associated with the G2/M transition, including the master cell‐cycle regulator, cell‐cycle‐dependent kinase 1 (CDK1), resulting in cell‐cycle arrest at G2/M. Our findings demonstrate that TAF1D is a key oncogenic regulator of MYCN‐amplified HR‐NB and suggest that therapeutic targeting of TAF1D may be a viable strategy to treat HR‐NB patients by blocking cell‐cycle progression and the proliferation of tumor cells. [ABSTRACT FROM AUTHOR]

Published
2023
Full Text
View/download PDF

98. Aberrant Topological Properties of Brain Functional Network in Children with Obstructive Sleep Apnea Derived from Resting-State fMRI

Author

Ji, Tingting, primary, Ren, Xuemin, additional, Long, Ting, additional, Li, Xiaodan, additional, Mei, Lin, additional, Ge, Wentong, additional, Zhang, Jie, additional, Wang, Shengcai, additional, Guo, Yongli, additional, Xu, Zhifei, additional, Peng, Yun, additional, Liu, Jiangang, additional, Tai, Jun, additional, and Ni, Xin, additional

Published
2022
Full Text
View/download PDF

Catalog

Books, media, physical & digital resources
See catalog results